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A continuous end-to-end synthesis and purification of diphenhydramine hydrochloride featuring atom 
economy and waste minimization is described.  Combining a 1:1 molar ratio of the two starting material 
streams (chlorodiphenylmethane and N,N-dimethylaminoethanol) in the absence of additional solvent at 
high temperature gives the target compound directly as a molten salt (ionic liquid above 168 °C) in high 10 
yield.  This represents the first example of continuous active pharmaceutical ingredient (API) production 
in this manner. Six of the twelve principles of green chemistry as defined by the American Chemical 
Society are achieved, most prominently waste minimization and atom economy. 
Introduction 
Discovered nearly seventy years ago by George Rieveschl,1 15 
diphenhydramine (1, Figure 1) is an important H1-antagonist still 
in modern use.  It is the most prominent of the ethanolamine-
based antihistamines and among other applications is used to treat 
the common cold, lessen symptoms of allergies, and act as a mild 
sleep aid.  The HCl salt form of diphenhydramine (2) is the active 20 
pharmaceutical ingredient in well-known over-the-counter 
medications such as Benadryl, Zzzquil, Tylenol PM, and Unisom.  
As a well-established treatment, little recent research has been 
invested in the production of this compound.  Nevertheless, 
because the global demand of diphenhydramine is large by 25 
pharmaceutical standards (>100 tonnes per annum), improved 
manufacturing via continuous flow synthesis may offer several 
advantages.  Described herein is such a synthesis of 
diphenhydramine hydrochloride (2, Figure 1) that features 
flowing of this substance as a neat, molten ammonium salt 30 
through the reactor as it forms, atom economy, avoidance of 
solvent, and minimal post-synthesis processing. 
 Use of continuous manufacturing in this application illustrates 
six of the twelve principles of green chemistry as described by 
the ACS.2  Highlighted are waste minimization, atom economy 35 
(incorporation of all atoms of starting material into final product), 
the design of less hazardous chemical synthesis (elimination of 
chlorobenzene as a solvent, commonly used in manufacturing of 
2), the elimination of auxiliaries and solvents (solvent use in 
synthesis eliminated and reduced in processing)), reduced 40 
derivatization (no Br–/Cl– counter-ion exchange, commonly 
performed in manufacturing of 2), and inherently safe chemistry 
for accident prevention (small reactor, decreased amount of 
chemicals reacting at any point). 
 45 
 
Fig. 1.  Continuous end-to-end synthesis, purification, and crystallization 
of diphenhydramine hydrochloride (2). 
Continuous production (CP) has gained considerable traction in 
the pharmaceutical and fine chemicals manufacturing industries.3  50 
Interest stems from potential cost and savings,4 process 
intensification,5 and improved performance in relation to batch 
operations.6  Comprehensive summaries of chemical synthesis 
conducted in flow and discussions of the associated benefits have 
appeared in the past several years.7   55 
 Continuous flow chemistry also appears to be particularly well 
poised to contribute to the movement toward green, sustainable 
processes.  For example, the ACS Presidential Roundtable on 
Sustainable Manufacturing (SMRT), lists process intensification 
as the top priority for Next Generation Chemical Manufacturing, 60 
where continuous flow is largely detailed as the solution.8  
Furthermore, the ACS Green Chemistry Institute (GCI), in 
partnership with several global pharmaceutical companies, 
described several key research areas for sustainable 
manufacturing.9  The most critical field was voted to be 65 
continuous processing (CP), and the positive impact of CP on 
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several other of the prioritized research areas was also averred. 
 Also unequivocally clear was the importance of improved 
post-synthetic handling and processing of material (e.g., 
crystallizations, separations, chromatography, drying, and other 
forms of purification). With all of these considerations in mind, 5 
we set out to develop an end-to-end continuous process for the 
synthesis, purification, and crystallization of diphenhydramine 
(Figure 1).  
Results and Discussion 
Diphenhydramine is generally synthesized via one of two 10 
sequences.  Rieveschl’s original approach, which employs N,N-
dimethylaminoethanol (DMAE, 3), bromodiphenylmethane (5), 
base, and solvent, continues to be used today on production scale 
(batch).10 
 The second involves p-toluenesulfonic acid-promoted 15 
etherification of benzhydrol (6) by DMAE,11 which is amenable 
to flow synthesis, provided that water is removed from solution in 
order to shift the equilibrium in the desired direction á la Le 
Chatelier.  We effected this tactic by allowing water to vaporize 
as it formed in a flow reactor, and use of a 75 psi back-pressure 20 
regulator (bpr) was optimal.  (See Supporting Information for 
details.)  Lower pressure bprs were not as effective because the 
greater volume of the vaporized water significantly shortened the 
residence time and led to incomplete conversion.  Alternatively, 
higher pressure bprs kept water in the condensed phase.  Without 25 
removal of water in this fashion, the yield of the desired peaked 
near 30%, and in all cases, self-condensation of benzhydrol to 
give dibenzhydryl ether (7) was a significant competing process.  
Variation of the 2-aminoethanol stoichiometry was not effective 
in producing the desired ether in greater than 67% yield, and thus 30 
this route was abandoned.  
 Our focus next turned toward using bromodiphenylmethane (5) 
as a starting material (Table 1, entries 1-5).  N-
methylpyrrolidinone was chosen as a high-boiling-point solvent 
capable of solvating the high concentrations of ammonium salts 35 
(2.0 M) formed in situ. Thus, aminoalcohol 3 was pumped as a 
neat liquid in the absence of an external base, and the solution 
was heated at 140 °C with a residence time (tR) of 5 min.  After 
work up with aqueous sodium hydroxide, 47% yield of desired 1 
was obtained, along with concomitant production of benzhydrol 40 
and ether 7.  As elevated temperature might be the cause of side-
product generation from reaction with solvent or adventitious 
water, lower temperature was explored.  Below 140 °C, 
significantly less diphenhydramine was produced, despite the 
observation that all starting material had been consumed.  The 45 
mass balance based on consumption of 5 was likely due to 
conversion to benzhydrol in the quench with aqueous base.  
Elevating the temperature to 160 or 180 °C led to considerable 
gains in yield, but not beyond 77%.  Use of excess aminoalcohol 
(up to 1.6 equiv) provided only modest gains in yield, reaching a 50 
maximum of 82%.  Higher dibenzyl halide concentrations 
resulted in clogging of the reactor. 
 Chlorodiphenylmethane (4) was thus examined with the hope 
that a less reactive dibenzyl halide might lead to more selective 
product formation (entries 6-8) and that it would also provide a 55 
means to synthesize the necessary HCl salt form directly, thus 
avoiding subsequent counterion exchange.  Conditions identical  
Table  1. Diphenhydramine and by-products afforded in NMP.a 
Entry X Temp (°C) tR (min) 1:6:7:SM Yield
b 
1 Br, 5 100 5 21:69:10:0 7% 
2 Br, 5 120 5 43:48:8:0 13% 
3 Br, 5 140 5 71:22:7:0 47% 
4 Br, 5 160 5 87:5:8:0 77% 
5 Br, 5 180 5 82:5:13:0 70% 
6 Cl, 4 180 5 63:5:6:25 59% 
7 Cl, 4 180 10 77:5:8:10  73% 
8 Cl, 4 180 20 86:4:8:2 80% 
a) See Experimental for details. b) Yield determined from 1H NMR with 
external standard. 60 
to those found above led to 59% yield, with marked quantities of 
starting material observed after quench.  An increase in residence 
time effected conversion of the majority of remaining starting 
material giving 80% yield.   
 Unlike 5, chlorodiphenylmethane possesses a low melting 
point, slightly below room temperature.  Side-product formation 
might stem from participation by the solvent, either by reacting 
directly with halodiphenylmethane or from the presence of 
adventitious water.  Rather than examining other solvents with 70 
large dielectric constant such as N,N-dimethylformamide (DMF), 
where oxygen atom abstraction should more readily occur, or 
dimethyl sulfoxide (DMSO) which would oxidize the dibenzyl 
halide, our attention was turned to running the reaction even more 
simply:  neat, with excess aminoalcohol (if necessary) 75 
functioning as solvent (Table 2).   
 Eliminating the use of solvent and incorporating a threefold 
excess of 3 improved the transformation significantly (entry 1).  
Neat 4 and aminoalcohol were flowed together in a 1:4 ratio 
(corresponds to [chlorodiphenylmethane]0 = 1.75 M, i.e., similar 80 
 
 
Table 2. Elimination of solvent under continuous flow parameters for the 
synthesis of diphenhydramine.a 
Entry Equiv 3 tR (min) Temp (ºC) 1:6:7:4 Yield
b 
1 4 16 175 97:3:0:0 91% 
2 3 16 175 98:2:0:0 92% 
3 2 16 175 96:2:2:0 91% 
4 1 16 175 92:4:4:0 86% 
5 1 32 175 89:4:7:0 85%b 
6 1 16 200 93:1:6:0 78%b 
a) See Experimental for details. b) Average yield obtained in three runs (1H 85 
NMR, external standard).  c) Single experiment. 
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concentration to studies with added solvent (above).  With a 
reactor temperature of 175 °C (tR = 16 min), 91% yield was 
obtained.  Significantly, very little benzhydrol and ether 7 were 
observed.  To prevent crystallization of the desired hydrochloride 
salt 2 in the flow reactor (and hence, clogging), DMSO was 5 
plumbed into the reaction mixture as a carrier solvent. Decreasing 
the amount of DMAE to a twofold or molar excess (1:3 and 1:2 
ratio of 4:3, respectively) maintained the benefits of solvent 
avoidance and flow of neat reagents (entries 2 and 3). 
 Excess DMAE could be eliminated entirely; however, this 10 
approach requires flowing of the highly crystalline product.  
Nevertheless, with a melting point of 168 °C, the product API 
could be handled (flowed) as an ionic liquid.  Several recent 
reports detail the solventless continuous synthesis of ionic 
liquids.12  Nevertheless, the melting point of diphenhydramine 15 
hydrochloride is significantly higher than these compounds, and 
this tactic has not been used for the production of 
pharmaceuticals.   
 This approach (neat, 1:1 stoichiometry, product as ionic liquid) 
met with experimental success.  PFA tube reactors with 0.03” 20 
inner diameter (i.d.) were prone to rupture, but narrower tubing 
(0.02” i.d.), i.e., thicker walled, provided the requisite strength.  
A yield of 86% was obtained at 175 °C (tR = 16 min).  This serves 
as the first example of continuous synthesis of API as an ionic 
liquid.  Additionally, the method presents a solution to solid 25 
formation in continuous processes, still a major obstacle in the 
production of pharmaceuticals,13 and with recent interest centered 
on the formulation of APIs as ionic liquids,14 this strategy might 
find additional applicability. Higher temperatures and longer 
reaction times led to greater byproduct formation. Duplication of 30 
this result in batch on significant scale would be greatly 
complicated by crystallization of the cooling ammonium salt 
during transport and handling. 
 Small amounts of diphenylmethane, 1,1’,2,2’-
tetraphenylethane (8), and benzophenone (9) accounted for the 35 
remainder of mass balance in the reaction.  Tetraphenylethylene 
(10) and dichlorodiphenylmethane (11) were not observed.  
Homolytic cleavage of the carbon-chlorine bond, caused 
thermally, by light, or adventitious oxygen would account for the 
observed byproducts, and thus we investigated this possibility.  40 
Consistent with this notion was the observation that, trace 
amounts of benzophenone (which could provide 
photosensitization) would appear over time in samples of the 
chlorodiphenylmethane starting material. Chlorodiphenylmethane 
was thus recrystallized from hexanes at –30 °C, removing all 45 
impurities.  The reaction was then conducted with the purified 
material, but byproduct formation was not suppressed.  To 
prevent interference from light, the heating bath was shielded 
with Al foil, but this modification did not alter the reaction 
outcome.  In the event that dissolved oxygen was the culprit, 50 
argon was bubbled through reagents prior to loading in syringes, 
but again byproduct formation persisted.  Finally, butylated 
hydroxytoluene (12, BHT, 10 wt. %) was added to the DMAE 
feedstock in order to scavenge possible radicals in solution.  
Nevertheless no change in product distribution was noted.  These 55 
changes suggest that deleterious radical formation do not 
contribute to the generation of the observed by-products. 
 With a continuous synthetic pathway developed, we shifted  
Table 3. Optimization of in-line quench, separation, and crystallization.a 
Entry Equiv 3 1:6:7:4 
Yield 
(ext)b 
Yield 
(cryst)c 
1 4 99:1:0:0 89 93 
2 3 98:2:0:0 89 89 
3 2 97:2:1:0 93 92 
4 1 97:1:1:1 88 83 
a) See Experimental for details. b) Average yield obtained in three runs (1H 60 
NMR, external standard).  c) Isolated yield, average of three runs. 
our attention to post-synthetic processing of the API (Table 3).  
Any excess DMAE would lead to a mixture of 
dimethylaminoethanol hydrochloride (13) and diphenhydramine 
hydrochloride.  As a result, a continuous in-line extraction was 65 
developed to yield the desired ammonium salt 2.  Since the 
appearance of continuous liquid-liquid separations in 
microreactors via selectively wettable membranes,15 several 
applications of the technology have been reported in the synthesis 
community.16   70 
 In place of DMSO, preheated aqueous NaOH (3 M) was 
combined with the reaction stream to neutralize ammonium salts 
2 and 13.  When not preheated, the reaction and neutralization 
mixtures did not combine in a homogeneous fashion and upon 75 
cooling of the API, the reactor clogged.  Upon exiting the 
pressurized system, hexanes were added to extract the neutralized 
tertiary amine 1 in conjunction with an in-line separator to 
remove the aqueous waste.  To the hexanes solution, 5 M HCl in 
isopropanol was added in order to precipitate diphenhydramine 80 
hydrochloride.  The separation proceeded smoothly and with 
minimal product loss, giving approximately 90% overall yield. 
 Choice of extraction solvent, acid source, and method of 
neutralization were all very important in successful production of 
solid API under continuous conditions.  Extraction with ethyl 85 
acetate and ether were effective; however, they dissolved enough 
water so that the ammonium salt precipitated as an oil, rather than 
a powder (Karl Fischer titration, >20,000 ppm H2O).  Chloroform 
absorbed less water (<700 ppm H2O) but prevented precipitation 
of the salt.  In contrast, hexanes absorbed minimal water after 90 
extraction (<150 ppm H2O) and induced very rapid precipitation 
of diphenhydramine hydrochloride salt.  Product purity was 
above 95% when only 1 or 2 equivalents of 3 were added.  No 
specified impurities are established by the US Pharmacopeia, but 
the recently developed system of Myerson and coworkers could 95 
possibly be employed to reach the requisite 98% purity level of 
2.17 
 We reasoned that solutions to these problems would be 
realized by direct crystallization of 2 from the reaction stream, 
which would also provide a further improvement to the 100 
purification process of diphenhydramine.  Waste associated with 
extraction would be minimized, and in principle, the HCl formed 
in situ from condensation could be used to formulate the 
hydrochloride salt of 1.  The use of equivalent stoichiometries of  
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Table 4.  Atom economy and waste minimization via direct 
crystallization of 2 from isopropanol.a 
Entry 
Isopropanol : Rxn 
Mixtureb Yieldc 2 : 13 
1 3 : 1 73 % 13.0 : 1 
2 2 : 1 71 % 15.7 : 1 
3 1 : 1 84 % 13.6 : 1 
a) See Experimental for details. b) Volume of isopropanol mixed with 
reaction stream. c) Yield from 1H NMR with external standard. 
4 and 3 affords this possibility through elimination of excess 5 
DMAE (Table 4).  Heated isopropanol joined the reaction stream 
post-synthesis but before the back-pressure regulator in order to 
prevent crystallization in the reactor prior to collection.  Using 
either two or three parts of isopropanol compared to volume of 
reaction mixture resulted in approximately 70% yield of 10 
diphenhydramine after cooling to room temperature.  The 
maximum yield, 84%, was obtained using 1 part isopropanol, but 
some N,N-dimethylaminoethanol hydrochloride salt persisted 
(approx. 6%).  Excess DMAE hydrochloride can easily be 
removed by a subsequent recrystallization from isopropanol. 15 
Conclusions 
Placing a new twist on a venerable compound, a very effective 
end-to-end continuous flow process was developed for the 
synthesis of benadryl with a number of advantages, real-time in-20 
line purification being among them.  With solvent minimization, 
waste of the continuous flow process is greatly reduced, leading 
to lower operation costs and hazards associated with excess and 
disposal.  The ability to heat well above the boiling point of all 
reaction components (particularly DMAE) affords high rates of 25 
reaction, and the resultant molten salt can be easily handled and 
transported via pumping, an operation likely to be troublesome 
under batch conditions on any significant scale.  Additionally, the 
synthesis achieves complete atom economy, taking the product of 
condensation, HCl, and directing it toward formulation of the API 30 
itself.  
 Finally, the 1:1 ratio of starting materials provides the added 
benefit of high throughput and production rate.  With our 720 µL 
reactor serving as a model system and equal stoichiometry of 
reactants, 2.42 g/h of API 2 can be produced.  When 4 equiv of 35 
DMAE are used the output decreases to 1.23 g/h.  Real-time 
crystallization affords similar reductions in waste when compared 
to a process utilizing extractions.  With direct crystallization from 
isopropanol and a 1:1 ratio of chlorodiphenylmethane to DMAE, 
3.13 mL/h of waste is generated, whereas, the extraction process 40 
would produce 23.2 mL/h of waste.  This study also demonstrates 
the feasibility of directly synthesizing an API salt form neat (no 
added solvent) by taking advantage of the ability to flow molten 
ammonium salts (i.e., above the melting point of the salt), a 
strategy that would be of limited utility in large scale batch 45 
manufacturing.  As this feature highlights many principles of 
green chemistry by providing significant process intensification, 
throughput increases, equipment footprint reduction, and 
minimization of waste, we are currently investigating the 
generality of this approach to the continuous manufacturing and 50 
purification of pharmaceuticals. 
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Experimental 
Solvents and reagents were purchased from Sigma-Aldrich and 60 
used as received.  Reactors were constructed from high-purity 
PFA tubing bought from Upchurch Scientific with 0.03” i.d. 
when employing NMP or 0.02” i.d. when solventless conditions 
were used.  Harvard Apparatus PhD Ultra syringe pumps were 
used to pump reagents and solutions from 8 mL stainless steel 65 
syringes.  Pressure was controlled using 250 psi back-pressure 
regulator cartridges from IDEX.  Reagent streams were combined 
using Tefzel T-mixers with 0.02” i.d. (IDEX), and reaction 
mixture and post-synthethic carrier streams were combined in a 
stainless-steel T-mixer with 0.04” i.d. (IDEX) heated at 175 °C. 70 
 The separator employed was constructed from two stainless 
steel plates sandwiching a Zefluor membrane (pore size, 1.0 μM, 
see Supporting Information for diagram).  Identical channels 
were etched into each stainless steel plate causing fluid to 
proceed through the path in a repeating U-shaped zig-zag pattern.  75 
The groove cut into each plate was 1 mm in depth, 2 mm wide, 
and had a total path length of 157 mm.  One plate, designated as 
A, had two ports one at the beginning of the groove, the other at 
the end of the groove.  The other plate, designated as B, had only 
one port which was at the end of the groove.  The 316 Stainless 80 
Steel plates were manufactured in the MIT central machine shop.  
A pressure differential was established across the membrane by 
placing different lengths of tubing at the exit ports.  A 100 cm 
segment of tubing (0.03” i.d.) was placed at exit Port A, and a 30 
cm segment of tubing (0.03” i.d.) was placed at Exit Port B.  The 85 
biphasic mixture entered the separation channel from the entry 
port on Plate A.  The aqueous layer, after passing through the 
channel, exited the separator without wetting the Zefluor 
membrane through a port at the end of the groove also on Plate A.  
The organic layer wet the Zefluor membrane upon passing 90 
through the separation channel, and exited the extraction chamber 
through a port at the end of the groove on Plate B.   
 For each data point, sample was collected in a scintillation vial 
over 5 minutes.  Analysis was conducted in triplicate, with 
average values taken.  Yield and ratios were determined either by 95 
NMR or by mass and isolated yield.   Mesitylene was used as an 
external standard to diphenhydramine. T1 spin-lattice relaxation 
times were measured for all signals in the system and a delay 
time of 30 seconds was applied between pulses.  Multipoint 
baseline correction was applied to all spectra along with line-100 
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broadening equal to peak width at half-height.  
 
Diphenhydramine 1. Method A, NMP as solvent: Either 
bromodiphenylmethane (3.95 g, 16.0 mmol) or 
chlorodiphenylmethane (3.24 g, 16.0 mmol) was dissolved in 5 
NMP to give 8 mL of a 2.0 M solution.  The solution was loaded 
into a Harvard Apparatus stainless steel syringe.  DMAE was 
drawn into a second stainless steel syringe (8.0 mL, 9.93 M).  A 
720 μL reactor was constructed from 0.03” i.d. high purity PFA 
tubing, and the system was pressurized to 250 psi.  To give a 5 10 
min TR, the halodiphenylmethane solution was pumped at a rate 
of 120 μL/min and the aminoalcohol was pumped at 24 μL/min.  
Flow rates were adjusted accordingly to give different times of 
reaction.  After four residents, reaction solution was collected for 
analysis.  Sample was collected for five minutes, diluted with 4 15 
mL of 3M NaOH solution (aq.) and 2 mL of diethyl ether.  
Diphenhydramine was extracted from the aqueous layer and the 
procedure was repeated twice more.  The organic fractions were 
collected, dried with MgSO4, and concentrated.  Mesitylene (167 
μL, 1.20 mmol) was added to the diphenhydramine oil and mixed 20 
along with CDCl3.  The thoroughly mixed solution was analyzed 
by 1H NMR.  1H NMR (400 MHz, CDCl3) δ 7.58–7.19 (m, 10H), 
5.44 (s, 1H), 3.65 (t, J = 6.0 Hz, 2H), 2.68 (t, J = 6.0 Hz, 2H), 
2.35 (s, 6H). 
 25 
Method B, no reaction solvent and DMSO used as a carrier post 
reaction:  Chlorodiphenylmethane was loaded into a stainless 
steel syringe (8.0 mL, 5.62 M) as was DMAE (8.0 mL, 9.93 M).  
A 720 μL reaction loop was constructed from 0.02” i.d. high 
purity PFA tubing.  To afford a 16 minute TR, a total flow rate of 30 
45 μL was employed.  When 4 equivalents of DMAE were 
present, chlorodiphenylmethane flowed at 13.8 μL/min and 
DMAE at 31.2 μL/min.  DMSO was pumped at 180 μL/min and a 
120 μL loop of the solvent was preheated to the temperature of 
the reaction prior to joining the diphenhydramine hydrochloride 35 
at a stainless steel T-mixer (0.04” i.d.) also heated to the 
temperature of the reaction.  The DMSO/diphenhydramine 
hydrochloride mixture flowed through a 120 μL segment of 
tubing for mixing before exiting the 250 psi back-pressure 
regulator.  Four residents were allowed to pass prior to collecting 40 
a 5 minute sample for analysis which was diluted with 4 mL of 
3M NaOH solution (aq.) and 2 mL of diethyl ether.  
Diphenhydramine was extracted from the aqueous layer and the 
procedure was repeated twice more.  The organic fractions were 
collected, dried with MgSO4, and concentrated.  Mesitylene (54.0 45 
μL, 388 μmol) was added to the diphenhydramine oil and mixed 
along with CDCl3.  The thoroughly mixed solution was analyzed 
by 1H NMR.   
 
Method C, in-line quench, extraction, and crystallization: 50 
Chlorodiphenylmethane was loaded into a stainless steel syringe 
(8.0 mL, 5.62 M) as was DMAE (8.0 mL, 9.93 M).  A 720 μL 
reaction loop was constructed from 0.02” i.d. high purity PFA 
tubing.  To afford a 16 minute TR, a total flow rate of 45 μL was 
employed.  When 3 equivalents of DMAE were present, 55 
chlorodiphenylmethane flowed at 16.7 μL/min and DMAE at 
28.3 μL/min.  3 M NaOH (aq.) was pumped at 180 μL/min and a 
120 μL loop of the neutralizating agent was preheated to the 
temperature of the reaction prior to joining the reaction mixture at 
a stainless steel T-mixer (0.04” i.d.) also heated to the 60 
temperature of the reaction.  The NaOH/diphenhydramine 
hydrochloride mixture flowed through a 120 μL segment of 
tubing for mixing before exiting the 250 psi back-pressure 
regulator.  Hexane was flowed into the API stream at 180 μL/min 
and mixing was effected by passing the stream through a 405 μL 65 
coil of tubing prior to entering the separator.  The hexanes were 
collected after exiting Plate B.  To obtain the yield post-
extraction, sample was collected for five minutes and 
concentrated.  Mesitylene (65.3 μL, 470 μmol) was added as an 
external reference, and the sample was analyzed by 1H NMR.  To 70 
obtain yield from crystallization, 5 M HCl in isopropanol was 
added at 18.9 μL/min directly to a scintillation vial collecting 
sample from the separator.  The solution was rapidly stirred and 
an off-white solid precipitated.  The solid was washed twice with 
hexanes.  The solids were analyzed by elemental analysis and 1H 75 
NMR (D2O). 
1H NMR (400 MHz, D2O) δ 7.25 (m, 10H), 5.38 (s, 
1H), 3.56 (t, J = 5.0 Hz, 2H), 3.17 (t, J = 5.0 Hz, 2H), 2.70 (s, 
6H).  Anal Calcd for C17H22NOCl: C, 69.95; H, 7.60; N, 4.80.  
DMAE:7 = 1:1 Found: C, 69.59; H, 7.71; N, 4.81.  DMAE:7 = 
2:1 Found: C, 69.60; H, 7.68; N, 4.81.  DMAE:7 = 3:1 Found: C, 80 
69.43; H, 7.39; N, 4.82.  DMAE:7 = 4:1 Found: C, 69.36; H, 
7.45; N, 4.78. 
 
Method D, direct crystallization with isopropanol.  
Chlorodiphenylmethane was loaded into a stainless steel syringe 85 
(8.0 mL, 5.62 M) as was DMAE (8.0 mL, 9.93 M).  A 720 μL 
reaction loop was constructed from 0.02” i.d. high purity PFA 
tubing.  To afford a 16 minute TR, a total flow rate of 45 μL was 
employed.  When 1 equivalents of DMAE was present, 
chlorodiphenylmethane flowed at 28.7 μL/min and DMAE at 90 
16.3 μL/min.   Isopropanol was pumped at 45 μL/min and a 120 
μL loop of the crystallizing agent was preheated to the 
temperature of the reaction prior to joining the reaction mixture at 
a stainless steel T-mixer (0.04” i.d.) also heated to the 
temperature of the reaction.  The NaOH/diphenhydramine 95 
hydrochloride mixture flowed through a 120 μL segment of 
tubing for mixing before exiting the 250 psi back-pressure 
regulator.  After passing four residents of solution, sample for 
analysis was collected for five minutes.  After collecting, the 
sample was cooled to 5 ºC.  The mother liquor was decanted and 100 
the solid was rinsed twice with cold acetone.  The solid was 
dissolved in D2O and DMF was added as an external standard 
(62.7 μL, 807 μmol).  Yield and ratios were analyzed by 1H 
NMR. 
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